Picture of Replicel Life Sciences logo

RP — Replicel Life Sciences News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Development Deal For Greater China

July 11 (Reuters) - RepliCel Life Sciences Inc  RP.V :
    * REPLICEL LIFE SCIENCES ANNOUNCES SIGNED LICENSING AND
CO-DEVELOPMENT DEAL FOR GREATER CHINA
    * REPLICEL LIFE SCIENCES - SIGNED AGREEMENTS WITH YOFOTO
HEALTH
INDUSTRY SEALING PARTNERSHIP TO COMMERCIALIZE 3 OF REPLICEL'S
PROGRAMS IN GREATER CHINA
    * REPLICEL LIFE SCIENCES INC - YOFOTO'S UP-FRONT INVESTMENT
WILL
BE A CDN $5.1 MILLION PURCHASE OF SHARES AT CDN $0.95/SHARE
    * REPLICEL LIFE SCIENCES - YOFOTO'S UP-FRONT INVESTMENT TO
ALSO
INCLUDE 20% WARRANT COVERAGE EXERCISABLE AT CDN $0.95 PER SHARE
FOR A PERIOD OF 2 YEARS
    * REPLICEL LIFE SCIENCES-YOFOTO TO SPEND MIN OF C$7 MILLION
ON
REPLICEL PROGRAMS & CELL PROCESSING MANUFACTURING FACILITY OVER
NEXT 5 YEARS IN GREATER CHINA

Source text for Eikon:  ID:nCNW49CkRa 
Further company coverage:  RP.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Replicel Life Sciences

See all news